Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China · Delayed Price · Currency is CNY

31.11

-0.15 (-0.48%)

At close: Feb 13, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Self-produced Reagents	210.41M
Self-produced Reagents Growth	15.46%
Testing Services	23.49M
Testing Services Growth	-89.36%
Other Business	12.16M
Other Business Growth	47.51%
Scientific Research Services	6.14M
Scientific Research Services Growth	-29.00%
Purchased Reagents	6.01M
Purchased Reagents Growth	36.58%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	258.21M
China Growth	-39.14%